Literature DB >> 17294509

Stereospecific determination of cis- and trans-resveratrol in rat plasma by HPLC: application to pharmacokinetic studies.

Xijing Chen1, Hui He, Guangji Wang, Bing Yang, Weichao Ren, Le Ma, Qiaoling Yu.   

Abstract

A simple, accurate, precise, specific and reproducible high-performance liquid chromatography (HPLC) method was developed for simultaneous determination of resveratrol isomers in rat plasma. Cis-resveratrol was made by exposure of a trans-resveratrol solution to sunlight for 5 days followed by separation by HPLC and identification by mass spectrometry (MS). The assay procedure involved simple liquid-liquid extraction of resveratrol isomers and internal standard (IS, caffeine) from a small plasma volume directly into acetonitrile. The supernatant liquid was added an equal volume of water and injected onto a Hypersil ODS(2) C(18) column (5 microm, 4.6 x 250 mm). Mobile phase consisting of methanol and distilled water was used at a flow rate of 1.0 mL/min for the effective separation of cis-, trans-resveratrol and caffeine (IS). The detection of the analyte peak was achieved by monitoring the eluate using a UV detector set at 303 nm. The ratio of peak area of analyte to IS was used for quantification of plasma samples. Nominal retention times of cis-, trans-resveratrol and IS were 3.2, 4.3 and 6.1 min, respectively. The calibration curve was linear ranging from 0.066 to 6.64 and 0.134 to 13.4 microg/mL with correlation coefficients of 0.9998 and 0.9997 for trans and cis isomers, respectively. The absolute recovery of both isomers was more than 85%. The inter- and intra-day precisions in the measurement of quality control (QC) samples, 0.066, 0.664 and 6.64 microg/mL of trans-resveratrol, were in the range 2.37-6.95% relative standard deviation (RSD) and 0.77-6.97% RSD, respectively. The inter- and intra-day precisions in the measurement of quality control (QC) samples, 0.134, 1.34 and 13.4 microg/mL of cis-resveratrol, were in the range 1.93-3.72% relative standard deviation (RSD) and 1.13-6.57% RSD, respectively. Both analytes and IS were stable in the battery of stability studies and freeze-thaw cycles. Resveratrol isomers were found to be stable for a period of 30 days on storage at -20 degrees C. The application of the assay to determine the pharmacokinetic disposition after a single oral dose to rats is described.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17294509     DOI: 10.1002/bmc.747

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  12 in total

1.  Determination of resveratrol and its sulfate and glucuronide metabolites in plasma by LC-MS/MS and their pharmacokinetics in dogs.

Authors:  Miguel Muzzio; Zhihua Huang; Shu-Chieh Hu; William D Johnson; David L McCormick; Izet M Kapetanovic
Journal:  J Pharm Biomed Anal       Date:  2011-10-25       Impact factor: 3.935

2.  Activation energy of light induced isomerization of resveratrol.

Authors:  Teresa Sofia Figueiras; Maria Teresa Neves-Petersen; Steffen B Petersen
Journal:  J Fluoresc       Date:  2011-04-15       Impact factor: 2.217

3.  Resveratrol attenuates reproductive alterations in type 1 diabetes-induced rats.

Authors:  Joana Noguères Simas; Talita Biude Mendes; Camila Cicconi Paccola; Vanessa Vendramini; Sandra Maria Miraglia
Journal:  Int J Exp Pathol       Date:  2017-12-29       Impact factor: 1.925

4.  Antioxidant Activity of Resveratrol Diastereomeric Forms Assayed in Fluorescent-Engineered Human Keratinocytes.

Authors:  Ilaria Bononi; Paola Tedeschi; Vanessa Mantovani; Annalisa Maietti; Elisa Mazzoni; Cecilia Pancaldi; Vincenzo Brandolini; Mauro Tognon
Journal:  Antioxidants (Basel)       Date:  2022-01-20

5.  Resveratrol exerts a biphasic effect on apolipoprotein M.

Authors:  Makoto Kurano; Masumi Hara; Takahiro Nojiri; Hitoshi Ikeda; Kazuhisa Tsukamoto; Yutaka Yatomi
Journal:  Br J Pharmacol       Date:  2015-11-12       Impact factor: 8.739

6.  Comparative Evaluation of Solubility, Cytotoxicity and Photostability Studies of Resveratrol and Oxyresveratrol Loaded Nanosponges.

Authors:  Nilesh Kumar Dhakar; Adrián Matencio; Fabrizio Caldera; Monica Argenziano; Roberta Cavalli; Chiara Dianzani; Marco Zanetti; José Manuel López-Nicolás; Francesco Trotta
Journal:  Pharmaceutics       Date:  2019-10-20       Impact factor: 6.321

7.  Chemical, Manufacturing, and Standardization Controls of Grape Polyphenol Dietary Supplements in Support of a Clinical Study: Mass Uniformity, Polyphenol Dosage, and Profiles.

Authors:  Weiting Lyu; David Rodriguez; Mario G Ferruzzi; Giulio M Pasinetti; James W Murrough; James E Simon; Qingli Wu
Journal:  Front Nutr       Date:  2021-12-16

8.  Development and preclinical evaluation of microneedle-assisted resveratrol loaded nanostructured lipid carriers for localized delivery to breast cancer therapy.

Authors:  Shivaprasad Gadag; Reema Narayan; Archana S Nayak; Diana Catalina Ardila; Shilpa Sant; Yogendra Nayak; Sanjay Garg; Usha Y Nayak
Journal:  Int J Pharm       Date:  2021-07-10       Impact factor: 6.510

Review 9.  Properties of Resveratrol: In Vitro and In Vivo Studies about Metabolism, Bioavailability, and Biological Effects in Animal Models and Humans.

Authors:  J Gambini; M Inglés; G Olaso; R Lopez-Grueso; V Bonet-Costa; L Gimeno-Mallench; C Mas-Bargues; K M Abdelaziz; M C Gomez-Cabrera; J Vina; C Borras
Journal:  Oxid Med Cell Longev       Date:  2015-06-28       Impact factor: 6.543

10.  Nanoscale Delivery of Resveratrol towards Enhancement of Supplements and Nutraceuticals.

Authors:  Ana Rute Neves; Susana Martins; Marcela A Segundo; Salette Reis
Journal:  Nutrients       Date:  2016-03-02       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.